Characterization of Persister Cells Provides Insights into Mechanisms of Therapy Resistance in Neuroblastoma
AB Wolf, CP Reynolds, E Barbieri - Cancer Discovery, 2024 - aacrjournals.org
The study by Grossmann and colleagues uses single-nucleus RNA sequencing in a cohort
of matched high-risk neuroblastoma primary tumor samples, obtained from the same patient …
of matched high-risk neuroblastoma primary tumor samples, obtained from the same patient …
Screening and molecular mechanism research on bile microRNAs associated with chemotherapy efficacy in perihilar cholangiocarcinoma
S Fu, H Du, Y Dai, K Zheng, G Cao, L Xu, Y Zhong… - iScience, 2024 - cell.com
The efficacy of hepatic arterial infusion chemotherapy (HAIC) with oxaliplatin (OXA) and 5-
fluorouracil (5-Fu) for treating advanced perihilar cholangiocarcinoma (pCCA) has been …
fluorouracil (5-Fu) for treating advanced perihilar cholangiocarcinoma (pCCA) has been …
Lineage-dependence of the neuroblastoma surfaceome defines tumor cell state-dependent and independent immunotherapeutic targets
NM Kendsersky, M Odrobina, NW Mabe… - Neuro …, 2025 - academic.oup.com
Background Neuroblastoma is a heterogeneous disease with adrenergic (ADRN)-and
therapy resistant mesenchymal (MES)-like cells driven by distinct transcription factor …
therapy resistant mesenchymal (MES)-like cells driven by distinct transcription factor …